Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -86.70% | 19.74% | 3.44% | -5.52% | -36.27% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -88.89% | -33.33% | 133.33% | -- |
| Total Other Non-Cash Items | 2,559.20% | -90.25% | -98.27% | -92.97% | -88.64% |
| Change in Net Operating Assets | -19.00% | 112.47% | 230.55% | 391.87% | 571.45% |
| Cash from Operations | 45.89% | 36.52% | -6.47% | -4.55% | -113.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 146.84% | 200.00% | -- | -- |
| Cash from Investing | 100.00% | 134.18% | 187.34% | -- | -- |
| Total Debt Issued | -89.79% | -73.79% | -64.37% | -50.92% | 12.86% |
| Total Debt Repaid | 90.55% | 59.45% | 73.28% | 57.03% | 12.39% |
| Issuance of Common Stock | 58.75% | 522.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | -48.98% | -45.46% | 5.76% | 19.95% | 114.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.70% | -213.98% | 441.18% | 3,377.08% | 141.07% |
